Cargando…
Cancer Needs a Robust “Metadata Supply Chain” to Realize the Promise of Artificial Intelligence
Profound advances in computational methods, including artificial intelligence (AI), present the opportunity to use the exponentially growing volume and complexity of available cancer measurements toward data-driven personalized care. While exciting, this opportunity has highlighted the disconnect be...
Autores principales: | Chung, Caroline, Jaffray, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306309/ https://www.ncbi.nlm.nih.gov/pubmed/34853038 http://dx.doi.org/10.1158/0008-5472.CAN-21-1929 |
Ejemplares similares
-
Are There Specific Cancer Stem Cell Markers?
por: Lan, Linxiang, et al.
Publicado: (2023) -
Targeting the P53 Protein for Cancer Therapies: The Translational Impact of P53 Research
por: Levine, Arnold J.
Publicado: (2022) -
Dual Recombinase–Based Mouse Models Help Decipher Cancer Biology and Targets for Therapy
por: Sket, Tina, et al.
Publicado: (2023) -
Addressing Common Misuses and Pitfalls of P values in Biomedical Research
por: Wang, Ming, et al.
Publicado: (2022) -
Translating “Big Data” in Oncology for Clinical Benefit: Progress or Paralysis
por: Barker, Anna D., et al.
Publicado: (2022)